Successful treatment with tralokinumab in patients with atopic dermatitis and dupilumab‐induced psoriasis-Reference-Cited by-同舟云学术

Successful treatment with tralokinumab in patients with atopic dermatitis and dupilumab‐induced psoriasis

Published:2023-07-24 Issue:12 Volume:37 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Quattrini L.¹²,Caldarola G.¹²^ORCID,Falco G. M.¹²^ORCID,Pinto L. M.¹²,Peris K.¹²^ORCID

Affiliation:

1. Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale Università Cattolica del Sacro Cuore Rome Italy

2. UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche Fondazione Policlinico Universitario A. Gemelli – IRCCS Rome Italy

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.19351

Reference5 articles.

1. SchlösserAR ShareefM OlydamJ NijstenTEC HijnenDJ.Tralokinumab treatment for patients with moderate‐to‐severe atopic dermatitis in daily practice.2023;1–8.

2. Development of psoriasis during treatment with dupilumab: A systematic review

3. Psoriasiform dermatitis during dupilumab treatment for moderate‐to‐severe atopic dermatitis in children

4. Mutual Antagonism of T Cells Causing Psoriasis and Atopic Eczema

5. T Helper 2 IL-4/IL-13 Dual Blockade with Dupilumab Is Linked to Some Emergent T Helper 17‒Type Diseases, Including Seronegative Arthritis and Enthesitis/Enthesopathy, but Not to Humoral Autoimmune Diseases

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paradoxical Psoriasis;Dermatologic Clinics;2024-07

2. Paradoxical Psoriasis: An Updated Review of Clinical Features, Pathogenesis, and Treatment Options;Journal of Investigative Dermatology;2024-07

3. Interleukin antagonists for atopic dermatitis: a new era of therapy;Expert Opinion on Investigational Drugs;2024-06-02

4. Dupilumab;Reactions Weekly;2024-03-16

5. The associations between gut microbiota and inflammatory skin diseases: a bi-directional two-sample Mendelian randomization study;Frontiers in Immunology;2024-02-02